Chemoradiation for advanced hypopharyngeal carcinoma: a retrospective study on efficacy, morbidity and quality of life

Por Keereweer, Stijn, Kerrebijn, Jeroen D. F., Al-Mamgani, Abrahim, Sewnaik, Aniel, de Jong, Robert J. Baatenburg, van Meerten, Esther
Publicado em 2011

Gene-expression of metastasized versus non-metastasized primary head and neck squamous cell carcinomas: A pathway-based analysis

Por Hensen, Erik F, De Herdt, Maria J, Goeman, Jelle J, Oosting, Jan, Smit, Vincent THBM, Cornelisse, Cees J, de Jong, Robert J Baatenburg
Publicado em 2008

Illness cognitions in head and neck squamous cell carcinoma: predicting quality of life outcome

Por Scharloo, Margreet, de Jong, Robert J. Baatenburg, Langeveld, Ton P. M., van Velzen-Verkaik, Els, den Akker, Margreet M. Doorn-op, Kaptein, Adrian A.
Publicado em 2009

A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency

Por Punt, Simone, Dronkers, Emilie A. C., Welters, Marij J. P., Goedemans, Renske, Koljenović, Senada, Bloemena, Elisabeth, Snijders, Peter J. F., Gorter, Arko, van der Burg, Sjoerd H., de Jong, Robert J. Baatenburg, Jordanova, Ekaterina S.
Publicado no Cancer Immunol Immunother (2016)

In-vivo generation of bone via endochondral ossification by in-vitro chondrogenic priming of adult human and rat mesenchymal stem cells

Por Farrell, Eric, Both, Sanne K, Odörfer, Kathrin I, Koevoet, Wendy, Kops, Nicole, O'Brien, Fergal J, de Jong, Robert J Baatenburg, Verhaar, Jan A, Cuijpers, Vincent, Jansen, John, Erben, Reinhold G, van Osch, Gerjo JVM
Publicado em 2011

Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma

Por De Herdt, Maria J., Willems, Stefan M., van der Steen, Berdine, Noorlag, Rob, Verhoef, Esther I., van Leenders, Geert J.L.H., van Es, Robert J.J., Koljenović, Senada, de Jong, Robert J. Baatenburg, Looijenga, Leendert H.J.
Publicado no Oncotarget (2016)